Andrew Hollman Meyer

Insider Reports History

Location
La Jolla, CA
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Hollman Meyer:

Company Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Chief Business Officer Common Stock 83,095 $1,140,894 $13.73 02 Jan 2026 Direct
Janux Therapeutics, Inc. Chief Business Officer Stock Option (right to buy) 114,768 01 Dec 2025 Direct

Insider Reports Filed by Andrew Hollman Meyer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JANX Janux Therapeutics, Inc. 02 Jan 2026 1 -$25,799 4 Chief Business Officer 02 Jan 2026, 21:00
JANX Janux Therapeutics, Inc. 01 Dec 2025 4 -$74,633 4 Chief Business Officer 03 Dec 2025, 20:00
JANX Janux Therapeutics, Inc. 14 Nov 2025 3 -$64,694 4 Chief Business Officer 14 Nov 2025, 20:00
JANX Janux Therapeutics, Inc. 28 Oct 2025 5 -$388,298 4 Chief Business Officer 30 Oct 2025, 20:00
JANX Janux Therapeutics, Inc. 01 May 2025 4 -$92,713 4 Chief Business Officer 02 May 2025, 20:00
JANX Janux Therapeutics, Inc. 21 Apr 2025 3 -$85,984 4 Chief Business Officer 23 Apr 2025, 20:00
JANX Janux Therapeutics, Inc. 03 Mar 2025 4 -$93,138 4 Chief Business Officer 05 Mar 2025, 20:00
JANX Janux Therapeutics, Inc. 03 Feb 2025 5 -$126,963 4 Chief Business Officer 05 Feb 2025, 20:00
JANX Janux Therapeutics, Inc. 02 Jan 2025 7 -$731,785 4 Chief Business Officer 03 Jan 2025, 17:10
JANX Janux Therapeutics, Inc. 19 Dec 2024 4 +$199,985 4 Chief Business Officer 20 Dec 2024, 18:25
JANX Janux Therapeutics, Inc. 27 Sep 2024 3 -$2,087,255 4 Chief Business Officer 27 Sep 2024, 19:32
JANX Janux Therapeutics, Inc. 02 Jan 2024 1 $0 4 Chief Business Officer 03 Jan 2024, 16:50
JANX Janux Therapeutics, Inc. 03 Jan 2023 1 $0 4 Chief Business Officer 05 Jan 2023, 15:33
JANX Janux Therapeutics, Inc. 03 Jan 2022 1 $0 4 Chief Business Officer 05 Jan 2022, 16:26
JANX Janux Therapeutics, Inc. 10 Jun 2021 0 $0 3 Chief Business Officer 10 Jun 2021, 19:15